Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: CELLPHIRE, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2019-12-20 to 2024-06-19
Current total value of award: $19641957
Description: CLINICAL AND REGULATORY MANAGEMENT IN DIRECT SUPPORT OF EVENTUAL FDA APPROVAL OF A CRYOPRESERVED PLATELET (CPP) PRODUCT VIA THE PERFORMANCE OF GOOD CLINICAL PRACTICES (GCP) COMPLIANT PHASE 2 AND 3 CLINICAL TRIALS.